DNA修复基因单核苷酸多态性与铂类药物抵抗研究进展

被引：28

作者：

魏嘉 ^{[1
]}

刘宝瑞 ^{[1
]}

王亚平 ^{[2
]}

钱晓萍 ^{[1
]}

机构：

[1] 南京大学医学院附属鼓楼医院肿瘤中心南京大学临床肿瘤学研究所

[2] 南京大学医学院遗传学教研室

来源：

中华肿瘤杂志 | 2006年 / 03期

关键词：

多药耐药性; 单核苷酸多态性; DNA修复;

D O I：

暂无

中图分类号：

R730.5 [肿瘤治疗学];

学科分类号：

100214 ;

摘要：

引用

页码：161 / 163

页数：3

共 21 条

[1]

Molecularpredictorsofresponse tochemotherapyinlungcancer. RosellR,TaronM,ArizaA,etal. Seminars in Oncology . 2004

[2]

XPD,XPA,ERCC1andXPG/ERCC5singlenucleotidepolymorphisms(SNPs)inoxaliplatin treated colorectalcancer(CRC). VilaJM,MorenoI,MonzoM,etal. JClinOncol . 2004

[3]

XPDandXRCC1genetic polymorphismsareprognosticfactorsinadvancednon small celllung cancerpatientstreatedwithplatinumchemotherapy. GurubhagavatulaS,LiuG,ParkS,etal. JClinOncol . 2004

[4]

XPD/ERCC2polymorphismsand riskofheadandneckcancer:acase controlanalysis. SturgisEM,ZhengR,LiL,etal. Carcinogenesis . 2000

[5]

Modulationofnucleotideexcision repaircapacitybyXPDpolymorphismsinlungcancerpatients. SpitzMR,WuX,WangY,etal. Cancer Research . 2001

[6]

Influenceofgeneticmarkerson survivalinnon smallcelllungcancer. RosellR,TaronM,CampsC,etal. DrugsToday(Barc) . 2003

[7]

RelationshipbetweenXPG codon1104polymorphismandriskofprimarylungcancer. JeonHS,KimKM,ParkSH,etal. Carcinogenesis . 2003

[8]

PolymorphismsofDNArepairgenes XRCC1andXPDandtheirassociationswithriskofesophageal squamouscellcarcinomainaChinesepopulation. XingD,QiJ,MiaoX,etal. International Journal of Cancer . 2002

[9]

Amultivariateanalysisof genomicpolymorphisms:predictionofclinicaloutcometo5FU/oxaliplatincombinationchemotherapyinrefractorycolorectalcancer. StoehlmacherJ,ParkDJ,ZhangW,etal. British Journal of Cancer . 2004

[10]

GeneticpolymorphismsofXRCC1andriskofgastriccancer. LeeSG,KimB,ChoiJ,etal. Cancer Letters . 2002

← 1 2 3 →